Search for Clinical Trial Results

Sponsored By

ANCA-associated Vasculitis - 103 Studies Found

Status Study
Completed Study Name: A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Condition: ANCA-Associated Vasculitis
Date: 2016-12-11
Interventions:
  • Drug: CCX168 Orally administer
Terminated Study Name: Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
Condition: ANCA-Associated Vasculitis
Date: 2013-08-29
Interventions: Procedure: Venipuncture for blood sample collection Analysis samples from the blood sample collection at
Terminated Study Name: Abatacept in ANCA Associated Vasculitis
Condition: ANCA-associated Vasculitis
Date: 2007-06-01
Interventions: Drug: Abatacept (Orencia) 500mg for patients under 60kg 75
Completed Study Name: Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis
Condition: ANCA-associated Vasculitis
Date: 2014-08-19
Interventions:
  • Drug: CCX168 low dose plus standard of care
Completed Study Name: MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS
Condition: ANCA-associated Vasculitis
Date: 2016-11-02
Interventions: Other: Non interventional study This is a non interventional study because all levies are performed duri
Completed Study Name: Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis
Condition:
  • Pneumococcal Infection
  • ANCA-associated Vasculitis

Date: 2015-05-12
Completed Study Name: Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
Condition:
  • Pneumococcal Infection
  • ANCA-associated Vasculitis

Date: 2015-05-12
Active, not recruiting Study Name: CMV Modulation of the Immune System in ANCA-associated Vasculitis
Condition:
  • ANCA Associated Vasculitis
  • CMV Infection

Date: 2012-06-29
Interventions: Drug: Valaciclovir 2g q.d.s. orally for 6 months (dose adjusted according to renal function)
Active, not recruiting Study Name: Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab
Condition: ANCA-associated Vasculitides
Date: 2015-03-23
Interventions:
  • Drug: rituximab 500 mg rituxim
Active, not recruiting Study Name: WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
Condition: Systemic Wegener's Granulomatosis
Date: 2006-07-06
Interventions:
  • Drug: Azathioprine: 2 mg/kg/day
  • Drug: meth
Next >>>